Field of the Invention
This application is directed to pumps for mechanical circulatory support of a heart. In particular, this application is directed to devices used to position such pumps in a patient using percutaneous or catheter techniques.
Description of the Related Art
Heart disease is a major health problem that has high mortality rate. Physicians increasingly use mechanical circulatory support systems for treating heart failure. The treatment of acute heart failure requires a device that can provide support to the patient quickly. Physicians desire treatment options that can be deployed quickly and minimally-invasively.
Intra-aortic balloon pumps (IABP) are currently the most common type of circulatory support devices for treating acute heart failure. IABPs are commonly used to treat heart failure, such as to stabilize a patient after cardiogenic shock, during treatment of acute myocardial infarction (MI) or decompensated heart failure, or to support a patient during high risk percutaneous coronary intervention (PCI). Circulatory support systems may be used alone or with pharmacological treatment.
In a conventional approach, an IABP is positioned in the aorta and actuated in a counterpulsation fashion to provide partial support to the circulatory system. More recently minimally-invasive rotary blood pump have been developed in an attempt to increase the level of potential support (i.e. higher flow). A rotary blood pump is typically inserted into the body and connected to the cardiovascular system, for example, to the left ventricle and the ascending aorta to assist the pumping function of the heart. Other known applications pumping venous blood from the right ventricle to the pulmonary artery for support of the right side of the heart. An aim of acute circulatory support devices is to reduce the load on the heart muscle for a period of time, to stabilize the patient prior to heart transplant or for continuing support.
There is a need for improved mechanical circulatory support devices for treating acute heart failure. Fixed cross-section ventricular assist devices designed to provide near full heart flow rate are either too large to be advanced percutaneously (e.g., through the femoral artery without a cutdown) or provide insufficient flow.
There is a need for a pump with improved performance and clinical outcomes. There is a need for a pump that can provide elevated flow rates with reduced risk of hemolysis and thrombosis. There is a need for a pump that can be inserted minimally-invasively and provide sufficient flow rates for various indications while reducing the risk of major adverse events. In one aspect, there is a need for a heart pump that can be placed minimally-invasively, for example, through a 15FR or 12FR incision. In one aspect, there is a need for a heart pump that can be placed minimally-invasively and provide high flow rates but minimize obstruction of the vasculature through which the pump is placed. In one aspect, there is a need for a heart pump that can provide an average flow rate of 4 Lpm or more during operation, for example, at 62 mmHg of head pressure. While the flow rate of a rotary pump can be increased by rotating the impeller faster, higher rotational speeds are known to increase the risk of hemolysis, which can lead to adverse outcomes and in some cases death. Accordingly, in one aspect, there is a need for a pump that can provide sufficient flow while minimizing the likelihood of hemolysis at high rotational speeds. These and other problems are overcome by the inventions described herein.
Further, there is a need for providing an operative device of the pump capable of pumping blood at high flow rates while reducing the risk of hemolysis at the operative device. For example, when an impeller assembly is provided at the operative device, the high rate of rotation of the impeller may cause hemolysis, as blood flows past the high-speed impeller. Accordingly, there is a need for reducing the risk of hemolysis at the operative device of the pump, particularly when movable components are disposed at the operative device.
There is an urgent need for a pumping device that can be inserted percutaneously and also provide full cardiac rate flows of the left, right, or both the left and right sides of the heart when called for.
In one embodiment, a catheter system for a catheter pump is provided that includes an elongate body an impeller assembly, and a sheath. The elongated catheter body has a distal portion that includes an expandable cannula. The expandable cannula has an inlet and an outlet. The expandable cannula has a delivery profile and an operational profile larger than the delivery profile. The impeller assembly includes an impeller shaft and an impeller body that includes one or more blades. The impeller blade(s) draw fluid blood into the cannula when rotated in the fluid. The sheath has a cannula retention zone disposed over the expandable cannula and a separation zone. The cannula retention zone has a first configuration in which it is adapted to retain the expandable cannula in the delivery profile. The wherein the system is adapted to separate the separation zone into a first portion and a second portion disposed across a gap, the gap enabling the elongate catheter body to pass between the first and second portion so that the sheath can be removed from the elongate catheter body.
In another embodiment, a method is disclosed. The method can comprise advancing into the vasculature a catheter assembly. The catheter assembly can include an expandable cannula having an expandable impeller disposed therein and a sheath having a cannula retention portion disposed over the expandable cannula and the expandable impeller. The cannula retention portion can retain the expandable cannula and the expandable impeller in a low profile configuration. The method can further include providing relative motion between the sheath and the expandable cannula to expose the expandable cannula to permit the expandable cannula to expand to a high profile configuration. The high profile configuration can have a larger width than the low profile configuration. The first and second portions of the sheath can be separated along a longitudinal portion thereof to create a gap therealong. The method can include passing the elongate body through the gap to cause the sheath to be removed from the catheter assembly.
In yet another embodiment, a method is disclosed. The method can comprise disposing an introducer sheath in the vasculature of a patient. The method can include introducing a catheter assembly into the proximal end of the introducer sheath and into the vasculature through the introducer sheath. The catheter assembly can include an elongate body having an expandable cannula coupled with a distal end thereof. The catheter assembly can have an expandable impeller being journaled for rotation in the expandable cannula. The expandable impeller can be expanded for operation in a source of blood. The elongate body can be retracted into the introducer sheath such that the expandable cannula engages a distal end of the introducer sheath. Relative motion can be provided between the introducer sheath and the expandable cannula to compress the expandable cannula. The introducer sheath and the catheter assembly can be removed from the patient.
A more complete appreciation of the subject matter of this application and the various advantages thereof can be realized by reference to the following detailed description, in which reference is made to the accompanying drawings in which:
More detailed descriptions of various embodiments of components for heart pumps useful to treat patients experiencing cardiac stress, including acute heart failure, are set forth below.
This application is directed to apparatuses for inducing motion of a fluid relative to the apparatus. In particular, the disclosed embodiments generally relate to various configurations of devices for percutaneously delivering a distal portion of a catheter pump. As discussed in greater detail below, such devices provide reduced or minimized blood flow obstruction in the vasculature in which the catheter pump is disposed. For example, in the disclosed embodiments, one or more layers of a distal portion of the catheter assembly can be removed to reduce the profile of the distal portion during operation of the pump. In some embodiments a temporary protector is provided for expandable and/or delicate structures of a catheter pump assembly. In some of the disclosed embodiments, the function of collapsing an expandable portion of the catheter pump and of providing initial access to the vasculature is performed by the same structure.
I. Catheter Pump System and Method
A. Catheter Pump System
The pump 10 includes a motor driven by a controller 22. The controller 22 directs the operation of the motor 14 and an infusion system 26 that supplies a flow of infusate in the pump 10. A catheter system 80 that can be coupled with the motor 14 houses an impeller within a distal portion thereof. The catheter system 80 has a coupling 90 that can be engaged with the motor 14 in certain embodiments. In various embodiments, the impeller is rotated by the motor 14 when the pump 10 is operating. For example, the motor 14 can be disposed outside the patient. In some embodiments, the motor 14 is separate from the controller 22, e.g., to be placed closer to the patient. In other embodiments, the motor 14 is part of the controller 22. In still other embodiments, the motor is miniaturized to be insertable into the patient. Such embodiments allow the drive shaft to be much shorter, e.g., shorter than the distance from the aortic valve to the aortic arch (about 5 cm or less). Some examples of miniaturized motors catheter pumps and related components and methods are discussed in U.S. Pat. Nos. 5,964,694; 6,007,478; 6,178,922; and 6,176,848, all of which are hereby incorporated by reference herein in their entirety for all purposes.
B. Impeller and Cannula Features, Deployment, and Operation
With reference to
As shown in
Variations of the sheath assembly 88 are configured to be removed (e.g., by one or more seams) from the patient's body and in some cases entirely from the catheter body 84 to lower the profile of the portion of the catheter system 80 in the body. Removing the sheath assembly 88 has a number of benefits discussed further below including opening up space in the vasculature for blood flow around the remainder of the catheter system 80 that remains in the vasculature after the sheath assembly is removed. By providing such additional flow, the ability of the patient to tolerate the presence of the implanted portions of the pump 10 is enhanced. Catheter pumps typically have a large diameter relative to the access vessels and thus pose a meaningful risk of limb ischemia and other complications. Accordingly, even small reductions in diameter and increased blood flow around the device can be advantageous. Also, by enabling a portion of the catheter pump that is initially placed in the access vessel to be removed, a less invasive access technique can be provided. For example, the skin and blood vessel puncture can be smaller in size be removing one or more layers during or shortly after placement of the pump. For example, the presence of the body of the sheath contributes to the overall profile of the assembly passing through the skin and into the blood vessel. The skin and blood vessel can stretch for a short time which can enable the puncture to be the same size or even a bit smaller than the initial profile of the catheter assembly. By removing the sheath 88, the degree of stretch, the time during which the punctured tissues are stretched or both the degree and time are reduced which enables the punctures to be smaller and/or to avoid surgical cut-down while maintaining the size of the internal components (e.g., cannula, impeller, and drive shaft). These and other benefits and structures are discussed further below.
In the stored configuration, the impeller 300 and housing 202 have a diameter that is preferably small enough to be inserted percutaneously into a patient's vascular system. Thus, it can be advantageous to fold the impeller 300 and housing 202 into a small enough stored configuration such that the housing 202 and impeller 300 can fit within the patient's veins or arteries, particularly small veins or arteries that are peripheral and superficial, e.g., femoral veins or arteries, jugular and subclavian veins, radial and subclavian arteries. In some embodiments, therefore, the impeller 300 can have a diameter in the stored configuration corresponding to a catheter size between about 8 Fr and about 21 Fr. In one implementation, the impeller 300 can have a diameter in the stored state corresponding to a catheter size of about 7 Fr. In one implementation, the impeller 300 can have a diameter in the stored state corresponding to a catheter size of about 9 Fr. In one implementation, the impeller 300 can have a diameter in the stored state corresponding to a catheter size of about 10 Fr. In other embodiments, the impeller 300 can have a diameter in the stored configuration between about 12 Fr and about 21 Fr. For example, in one embodiment, the impeller 300 can have a diameter in the stored configuration corresponding to a catheter size of about 12-12.5 Fr.
When the impeller 300 is positioned within a chamber of the heart, however, it can be advantageous to expand the impeller 300 to have a diameter as large as possible in the expanded or deployed configuration. In general, increased diameter of the impeller 300 advantageously increases flow rate through the pump at a given rotational speed. A larger diameter impeller can also lead to an improved ratio of flow rate to hemolysis rate. In some implementations, the impeller 300 can have a diameter corresponding to a catheter size greater than about 12 Fr in the deployed configuration. In other embodiments, the impeller 300 can have a diameter corresponding to a catheter size greater than about 21 Fr in the deployed or expanded configuration.
In various embodiments, it can be important to increase the flow rate of the heart pump while ensuring that the operation of the pump does not harm the subject. For example, increased flow rate of the heart pump can advantageously yield better outcomes for a patient by improving the circulation of blood within the patient. Furthermore, the pump should avoid damaging the subject. For example, if the pump induces excessive shear stresses on the blood and fluid flowing through the pump (e.g., flowing through the cannula), then the impeller can cause damage to blood cells, e.g., hemolysis. A high hemolysis rate over an extended period can lead to negative outcomes and complications for the subject like stroke, excessive bleeding, anemia, and hypertension. Also, the presence of the distal portion of the catheter system 80 within the body is at least partially obstructive. That is, the catheter body 84 blocks flow to an extent, e.g., to peripheral regions of the body and smaller branch arteries when applied in the arterial vasculature. The distal end 94 of the sheath assembly 88 also presents a blocking surface to blood following the outer surface of the body 84. As will be explained below, various cannula, system, and/or impeller parameters can affect the pump's flow rate as well as conditions within the subject's body.
When activated, the pump 10 can effectively increase the flow of blood out of the heart and through the patient's vascular system. In various embodiments disclosed herein, the pump 10 can be configured to produce a maximum flow rate (e.g. low mm Hg) of greater than 4 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, greater than 6 Lpm, greater than 6.5 Lpm, greater than 7 Lpm, greater than 7.5 Lpm, greater than 8 Lpm, greater than 9 Lpm, or greater than 10 Lpm. In various embodiments, the pump can be configured to produce an average flow rate of greater than 2 Lpm, greater than 2.5 Lpm, greater than 3 Lpm, greater than 3.5 Lpm, greater than 4 Lpm, greater than 4.25 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, or greater than 6 Lpm.
C. Exemplary Left Ventricle Support Application
II. Reducing the Catheter Assembly Profile in Operation
As noted above, one aspect of biocompatibility of the pump 10 is the degree to which it obstructs blood flow in the patient. That is, the catheter assembly 80 takes up some of the cross-sectional area of the blood vessels in which it is disposed. If the space occupied by one or more layers can be reduced or eliminated in one or more phases of operation of the pump 10 the flow of blood through the vasculature in which the pump is disposed and to branch vessels will be improved. Furthermore, while the sheath assembly 88 is very useful in maintaining the impeller assembly 92 in a low profile configuration for delivery, it is unnecessary during the actual operation of the pump 10. Because the distal end 94 of the sheath assembly 88 has some thickness it will necessarily create blockage and a disturbance in the flow of blood along the catheter body 84. That is blood may be flow in an organized manner along the body 84 just upstream of the distal end 94 but will be disrupted at the distal face of the distal end 94.
A. Removable Retainer For Impeller Assembly
At least a portion of the sheath assembly 404 is configured to separate from the elongate body 84 in a controlled manner at a selected time. This enables the catheter assembly 400 to be delivered as discussed below and then to permit the sheath assembly 404 to be removed from the body. In one embodiment, a separation zone 420 is provided along the elongate body 416 to enable the elongate body 416 to be opened such that the elongate body 84 can pass through the separation zone 420. In one embodiment, the separation zone 420 enables the elongate body 416 to be separated into a plurality of pieces or segments. In one embodiment, the separation zone 420 comprises a linear seam disposed along the elongate body 416. The separation zone 420 comprises two seams in one embodiment, one of the seams disposed along a first later side of the elongate body 416 and another of the seams disposed along a second later side of the elongate body 416. Two of a plurality of seams can be disposed at 180 degrees apart from each other on the elongate body 416.
The separation zone or zones 420 can have any suitable configuration that facilities separating the elongate body 416 into a plurality of pieces or that facilitates changing the configuration of the elongate body 416 from a tubular body to one or more sheet-like body. An advantage of such separation is that the sheath assembly 404 can be removed from the catheter assembly 400 without removing the motor coupling 90 from the proximal end of the system 400 and without greatly lengthening the elongate body 84.
In another embodiment, the separation zone 420 extends along the elongate body 416 and has a distal end that is proximal of the distal end 404. By spacing the distal end of the separation zone 420 from the distal end 408 of the elongate body 416 the outward load or shear or separation force that can be borne by the elongate body 416 can be greater adjacent to the distal end thereof. In one embodiment, the elongate body 416 can be configured such that a first outward force, or shear or separation force can be borne in a region adjacent to the proximal end 412 and a second outward force, shear, or separation force greater than the first outward force, shear, or separation force can be borne by the elongate body 416 adjacent to the distal end 408.
Different outward, shear, or separation force capability can be provided in any suitable manner. For example, the separation zone 420 can have a first seam in a proximal portion of the elongate body 416 and a second seam in a distal portion of the elongate body 416. The first and second seams can be disposed along a continuous line or plane, e.g., along an axis parallel to the longitudinal axis of the elongate body 416. The first seam can have a first plurality of bridges separated by space and the second seams can have a second plurality of bridges separated by space, the dimension of the bridges along the longitudinal axis being greater in the second seam than in the first seam. The first seam can have a first plurality of bridges spanning between and coupling expanses of the elongate body 416 on opposite sides of the separation zone, the bridges being separated by space. The second seams can have a second plurality of such bridges separated by space. The dimension of the bridges along the longitudinal axis of the separation zone 420 can be greater in the second seam than in the first seam. In another embodiment, the radial thickness (e.g., wall thickness or dimension transverse to the longitudinal axis) is greater in the second seam than in the first seam.
In one embodiment, a first lateral separation zone is provided along a first lateral side of the elongate body 416 and a second lateral separation zone is provided along a second lateral side of the elongate body 416. The first and second lateral sides can oppose each other, e.g., by being about 180 degrees apart. This is illustrated in connection with the embodiment of
B. Methods of Deployment of Catheter Pump with Removable Outer Sheaths
The impeller 300 and the cannula 202 are deployed by providing relative motion between these components and a distal end of the body 466 of the sheath assembly 454. Once the distal end of the body of the sheath assembly 454 is disposed proximally of the proximal end of the cannula 202 the cannula and the impeller 300 will have been permitted to expand. As this point, the sheath assembly 454 provides no role in the operation of the pump 10 and can be removed.
Removal of the sheath assembly 454 can be as illustrated and described in connection with
In one variation, the impeller 300 is configured to be retracted into a collapsed position prior to the collapsing of the cannula 202. A drive shaft that is coupled with the impeller 300 can be provided with a mechanism to shift the position of the impeller from a deployed position (as in
Once the distal portion of the catheter assembly 450 is disposed in the introducer I the introducer I and the distal portion of the catheter assembly 450 can be removed sequentially or together.
Although the inventions herein have been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present inventions. It is therefore to be understood that numerous modifications can be made to the illustrative embodiments and that other arrangements can be devised without departing from the spirit and scope of the present inventions as defined by the appended claims. Thus, it is intended that the present application cover the modifications and variations of these embodiments and their equivalents.
This application claims priority to U.S. Provisional Patent Application No. 61/979,937, filed Apr. 15, 2014, the contents of which are incorporated by reference herein in their entirety and for all purposes.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2015/026025 | 4/15/2015 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/160990 | 10/22/2015 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1902418 | Pilgrim | Mar 1933 | A |
2356659 | Aguiar | Oct 1942 | A |
2649052 | Weyer | Aug 1953 | A |
2664050 | Abresch | Dec 1953 | A |
2684035 | Kemp | Jul 1954 | A |
2789511 | Warren | Apr 1957 | A |
2896926 | Chapman | Jul 1959 | A |
2935068 | Donaldson | May 1960 | A |
3080824 | Boyd et al. | Mar 1963 | A |
3455540 | Marcmann | Jul 1969 | A |
3510229 | Smith | May 1970 | A |
3812812 | Hurwitz | May 1974 | A |
3860968 | Shapiro | Jan 1975 | A |
3904901 | Renard et al. | Sep 1975 | A |
3995617 | Watkins et al. | Dec 1976 | A |
4115040 | Knorr | Sep 1978 | A |
4129129 | Amrine | Dec 1978 | A |
4135253 | Reich et al. | Jan 1979 | A |
4143425 | Runge | Mar 1979 | A |
4149535 | Volder | Apr 1979 | A |
4304524 | Coxon et al. | Dec 1981 | A |
4382199 | Isaacson | May 1983 | A |
4392836 | Sugawara | Jul 1983 | A |
4458366 | MacGregor | Jul 1984 | A |
4540402 | Aigner | Sep 1985 | A |
4560375 | Schulte et al. | Dec 1985 | A |
4589822 | Clausen et al. | May 1986 | A |
4625712 | Wampler | Dec 1986 | A |
4655745 | Corbett | Apr 1987 | A |
4686982 | Nash | Aug 1987 | A |
4696667 | Masch | Sep 1987 | A |
4704121 | Moise | Nov 1987 | A |
4728319 | Masch | Mar 1988 | A |
4753221 | Kensey et al. | Jun 1988 | A |
4769006 | Papantonakos | Sep 1988 | A |
4817586 | Wampler | Apr 1989 | A |
4846152 | Wampler et al. | Jul 1989 | A |
4895557 | Moise et al. | Jan 1990 | A |
4900227 | Trouplin | Feb 1990 | A |
4902272 | Milder et al. | Feb 1990 | A |
4906229 | Wampler | Mar 1990 | A |
4908012 | Moise et al. | Mar 1990 | A |
4919647 | Nash | Apr 1990 | A |
4944722 | Carriker et al. | Jul 1990 | A |
4955856 | Phillips | Sep 1990 | A |
4957504 | Chardack | Sep 1990 | A |
4964864 | Summers et al. | Oct 1990 | A |
4969865 | Hwang et al. | Nov 1990 | A |
4976270 | Parl et al. | Dec 1990 | A |
4985014 | Orejola | Jan 1991 | A |
4994017 | Yozu | Feb 1991 | A |
4995857 | Arnold | Feb 1991 | A |
5000177 | Hoffman et al. | Mar 1991 | A |
5021048 | Buckholtz | Jun 1991 | A |
5045072 | Castillo et al. | Sep 1991 | A |
5049134 | Golding et al. | Sep 1991 | A |
5061256 | Wampler | Oct 1991 | A |
5089016 | Millner et al. | Feb 1992 | A |
5092844 | Schwartz et al. | Mar 1992 | A |
5098256 | Smith | Mar 1992 | A |
5106368 | Uldall et al. | Apr 1992 | A |
5112200 | Isaacson et al. | May 1992 | A |
5112292 | Hwang et al. | May 1992 | A |
5112349 | Summers et al. | May 1992 | A |
5129883 | Black | Jul 1992 | A |
5142155 | Mauze et al. | Aug 1992 | A |
5147186 | Buckholtz | Sep 1992 | A |
5163910 | Schwartz et al. | Nov 1992 | A |
5169378 | Figuera | Dec 1992 | A |
5171212 | Buck et al. | Dec 1992 | A |
5190528 | Fonger et al. | Mar 1993 | A |
5195960 | Hossain et al. | Mar 1993 | A |
5201679 | Velte et al. | Apr 1993 | A |
5211546 | Isaacson et al. | May 1993 | A |
5221270 | Parker | Jun 1993 | A |
5234407 | Teirstein et al. | Aug 1993 | A |
5234416 | Macaulay et al. | Aug 1993 | A |
5290227 | Pasque | Mar 1994 | A |
5300112 | Barr | Apr 1994 | A |
5312341 | Turi | May 1994 | A |
5344443 | Palma et al. | Sep 1994 | A |
5346458 | Affeld | Sep 1994 | A |
5360317 | Clausen et al. | Nov 1994 | A |
5376114 | Jarvik | Dec 1994 | A |
5393197 | Lemont et al. | Feb 1995 | A |
5393207 | Maher et al. | Feb 1995 | A |
5405341 | Martin | Apr 1995 | A |
5405383 | Barr | Apr 1995 | A |
5415637 | Khosravi | May 1995 | A |
5437541 | Vainrub et al. | Aug 1995 | A |
5449342 | Hirose et al. | Sep 1995 | A |
5458459 | Hubbard et al. | Oct 1995 | A |
5490763 | Abrams et al. | Feb 1996 | A |
5505701 | Anaya Fernandez de Lomana | Apr 1996 | A |
5527159 | Bozeman, Jr. et al. | Jun 1996 | A |
5533957 | Aldea | Jul 1996 | A |
5534287 | Lukic | Jul 1996 | A |
5554114 | Wallace et al. | Sep 1996 | A |
5588812 | Taylor et al. | Dec 1996 | A |
5609574 | Kaplan et al. | Mar 1997 | A |
5613935 | Jarvik | Mar 1997 | A |
5643226 | Cosgrove et al. | Jul 1997 | A |
5678306 | Bozeman, Jr. et al. | Oct 1997 | A |
5692882 | Bozeman et al. | Dec 1997 | A |
5702418 | Ravenscroft | Dec 1997 | A |
5704926 | Sutton | Jan 1998 | A |
5707218 | Maher et al. | Jan 1998 | A |
5722930 | Larson et al. | Mar 1998 | A |
5725513 | Ju et al. | Mar 1998 | A |
5725570 | Heath | Mar 1998 | A |
5730628 | Hawkins | Mar 1998 | A |
5735897 | Buirge | Apr 1998 | A |
5738649 | Macoviak | Apr 1998 | A |
5741234 | Aboul-Hosn | Apr 1998 | A |
5741429 | Donadio, III et al. | Apr 1998 | A |
5746709 | Rom et al. | May 1998 | A |
5749855 | Reitan | May 1998 | A |
5755784 | Jarvik | May 1998 | A |
5776111 | Tesio | Jul 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5776190 | Jarvik | Jul 1998 | A |
5779721 | Nash | Jul 1998 | A |
5807311 | Palestrant | Sep 1998 | A |
5814011 | Corace | Sep 1998 | A |
5824070 | Jarvik | Oct 1998 | A |
5851174 | Jarvik et al. | Dec 1998 | A |
5859482 | Crowell et al. | Jan 1999 | A |
5868702 | Stevens | Feb 1999 | A |
5868703 | Bertolero | Feb 1999 | A |
5888241 | Jarvik | Mar 1999 | A |
5888242 | Antaki et al. | Mar 1999 | A |
5911685 | Siess et al. | Jun 1999 | A |
5921913 | Siess | Jul 1999 | A |
5941813 | Sievers et al. | Aug 1999 | A |
5951263 | Taylor et al. | Sep 1999 | A |
5957941 | Ream | Sep 1999 | A |
5964694 | Siess et al. | Oct 1999 | A |
6007478 | Siess et al. | Dec 1999 | A |
6007479 | Rottenberg et al. | Dec 1999 | A |
6015272 | Antaki et al. | Jan 2000 | A |
6015434 | Yamane | Jan 2000 | A |
6018208 | Maher et al. | Jan 2000 | A |
6027863 | Donadio, III et al. | Feb 2000 | A |
6053705 | Schob et al. | Apr 2000 | A |
6056719 | Mickley | May 2000 | A |
6058593 | Siess | May 2000 | A |
6059760 | Sandmore et al. | May 2000 | A |
6068610 | Ellis et al. | May 2000 | A |
6071093 | Hart | Jun 2000 | A |
6083260 | Aboul-Hosn | Jul 2000 | A |
6086527 | Talpade | Jul 2000 | A |
6086570 | Aboul-Hosn et al. | Jul 2000 | A |
6106494 | Saravia et al. | Aug 2000 | A |
6113536 | Aboul-Hosn et al. | Sep 2000 | A |
6123659 | Le Blanc et al. | Sep 2000 | A |
6123725 | Aboul-Hosn | Sep 2000 | A |
6132363 | Freed et al. | Oct 2000 | A |
6135943 | Yu et al. | Oct 2000 | A |
6136025 | Barbut et al. | Oct 2000 | A |
6139487 | Siess | Oct 2000 | A |
6152704 | Aboul-Hosn et al. | Nov 2000 | A |
6162194 | Shipp | Dec 2000 | A |
6176822 | Nix et al. | Jan 2001 | B1 |
6176848 | Rau et al. | Jan 2001 | B1 |
6186665 | Maher et al. | Feb 2001 | B1 |
6190304 | Downey et al. | Feb 2001 | B1 |
6190357 | Ferrari et al. | Feb 2001 | B1 |
6200260 | Bolling | Mar 2001 | B1 |
6210133 | Aboul-Hosn et al. | Apr 2001 | B1 |
6210318 | Lederman | Apr 2001 | B1 |
6210397 | Aboul-Hosn et al. | Apr 2001 | B1 |
6214846 | Elliott | Apr 2001 | B1 |
6217541 | Yu | Apr 2001 | B1 |
6227797 | Watterson et al. | May 2001 | B1 |
6228063 | Aboul-Hosn | May 2001 | B1 |
6234960 | Aboul-Hosn et al. | May 2001 | B1 |
6234995 | Peacock, III | May 2001 | B1 |
6245007 | Bedingham et al. | Jun 2001 | B1 |
6245026 | Campbell et al. | Jun 2001 | B1 |
6247892 | Kazatchkov et al. | Jun 2001 | B1 |
6248091 | Voelker | Jun 2001 | B1 |
6254359 | Aber | Jul 2001 | B1 |
6254564 | Wilk et al. | Jul 2001 | B1 |
6287319 | Aboul-Hosn et al. | Sep 2001 | B1 |
6287336 | Globerman et al. | Sep 2001 | B1 |
6295877 | Aboul-Hosn et al. | Oct 2001 | B1 |
6299635 | Frantzen | Oct 2001 | B1 |
6305962 | Maher et al. | Oct 2001 | B1 |
6387037 | Bolling et al. | May 2002 | B1 |
6395026 | Aboul-Hosn et al. | May 2002 | B1 |
6413222 | Pantages et al. | Jul 2002 | B1 |
6422990 | Prem | Jul 2002 | B1 |
6425007 | Messinger | Jul 2002 | B1 |
6428464 | Bolling | Aug 2002 | B1 |
6447441 | Yu et al. | Sep 2002 | B1 |
6454775 | Demarais et al. | Sep 2002 | B1 |
6468298 | Pelton | Oct 2002 | B1 |
6503224 | Forman et al. | Jan 2003 | B1 |
6508777 | Macoviak et al. | Jan 2003 | B1 |
6508787 | Erbel et al. | Jan 2003 | B2 |
6517315 | Belady | Feb 2003 | B2 |
6517528 | Pantages et al. | Feb 2003 | B1 |
6527699 | Goldowsky | Mar 2003 | B1 |
6532964 | Aboul-Hosn et al. | Mar 2003 | B2 |
6533716 | Schmitz-Rode | Mar 2003 | B1 |
6544216 | Sammler et al. | Apr 2003 | B1 |
6547519 | de Blanc et al. | Apr 2003 | B2 |
6565598 | Lootz | May 2003 | B1 |
6609883 | Woodard et al. | Aug 2003 | B2 |
6610004 | Viole et al. | Aug 2003 | B2 |
6613008 | Aboul-Hosn et al. | Sep 2003 | B2 |
6616323 | McGill | Sep 2003 | B2 |
6623420 | Reich et al. | Sep 2003 | B2 |
6623475 | Siess | Sep 2003 | B1 |
6641093 | Coudrais | Nov 2003 | B2 |
6641558 | Aboul-Hosn et al. | Nov 2003 | B1 |
6645241 | Strecker | Nov 2003 | B1 |
6652548 | Evans et al. | Nov 2003 | B2 |
6660014 | Demarais et al. | Dec 2003 | B2 |
6673105 | Chen | Jan 2004 | B1 |
6692318 | McBride | Feb 2004 | B2 |
6709418 | Aboul-Hosn et al. | Mar 2004 | B1 |
6716189 | Jarvik et al. | Apr 2004 | B1 |
6749598 | Keren et al. | Jun 2004 | B1 |
6776578 | Belady | Aug 2004 | B2 |
6776794 | Hong et al. | Aug 2004 | B1 |
6783328 | Lucke et al. | Aug 2004 | B2 |
6790171 | Grundeman et al. | Sep 2004 | B1 |
6794784 | Takahashi et al. | Sep 2004 | B2 |
6794789 | Siess et al. | Sep 2004 | B2 |
6814713 | Aboul-Hosn et al. | Nov 2004 | B2 |
6817836 | Nose et al. | Nov 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6860713 | Hoover | Mar 2005 | B2 |
6866625 | Avre et al. | Mar 2005 | B1 |
6866805 | Hong et al. | Mar 2005 | B2 |
6887215 | McWeeney | May 2005 | B2 |
6889082 | Bolling et al. | May 2005 | B2 |
6901289 | Dahl et al. | May 2005 | B2 |
6926662 | Aboul-Hosn et al. | Aug 2005 | B1 |
6935344 | Aboul-Hosn et al. | Aug 2005 | B1 |
6942611 | Siess | Sep 2005 | B2 |
6949066 | Bearnson et al. | Sep 2005 | B2 |
6966748 | Woodard et al. | Nov 2005 | B2 |
6972956 | Franz et al. | Dec 2005 | B2 |
6974436 | Aboul-Hosn et al. | Dec 2005 | B1 |
6981942 | Khaw et al. | Jan 2006 | B2 |
6984392 | Bechert et al. | Jan 2006 | B2 |
7010954 | Siess et al. | Mar 2006 | B2 |
7011620 | Siess | Mar 2006 | B1 |
7014417 | Salomon | Mar 2006 | B2 |
7022100 | Aboul-Hosn et al. | Apr 2006 | B1 |
7027875 | Siess et al. | Apr 2006 | B2 |
7037069 | Arnold et al. | May 2006 | B2 |
7070555 | Siess | Jul 2006 | B2 |
7122019 | Kesten et al. | Oct 2006 | B1 |
7125376 | Viole et al. | Oct 2006 | B2 |
7144365 | Bolling et al. | Dec 2006 | B2 |
7150711 | Nusser et al. | Dec 2006 | B2 |
7160243 | Medvedev | Jan 2007 | B2 |
7172551 | Leasure | Feb 2007 | B2 |
7175588 | Morello | Feb 2007 | B2 |
7229258 | Wood et al. | Jun 2007 | B2 |
7241257 | Ainsworth et al. | Jul 2007 | B1 |
7262531 | Li et al. | Aug 2007 | B2 |
7264606 | Jarvik et al. | Sep 2007 | B2 |
7267667 | Houde et al. | Sep 2007 | B2 |
7284956 | Nose et al. | Oct 2007 | B2 |
7288111 | Holloway et al. | Oct 2007 | B1 |
7290929 | Smith et al. | Nov 2007 | B2 |
7329236 | Keren et al. | Feb 2008 | B2 |
7331921 | Viole et al. | Feb 2008 | B2 |
7335192 | Keren et al. | Feb 2008 | B2 |
7341570 | Keren et al. | Mar 2008 | B2 |
7381179 | Aboul-Hosn et al. | Jun 2008 | B2 |
7393181 | McBride et al. | Jul 2008 | B2 |
7469716 | Parrino et al. | Dec 2008 | B2 |
7491163 | Viole et al. | Feb 2009 | B2 |
7534258 | Gomez | May 2009 | B2 |
7605298 | Bechert et al. | Oct 2009 | B2 |
7619560 | Penna | Nov 2009 | B2 |
7633193 | Masoudipour et al. | Dec 2009 | B2 |
7645225 | Medvedev et al. | Jan 2010 | B2 |
7657324 | Westlund et al. | Feb 2010 | B2 |
7682673 | Houston et al. | Mar 2010 | B2 |
7722568 | Lenker et al. | May 2010 | B2 |
7731675 | Aboul-Hosn et al. | Jun 2010 | B2 |
7736296 | Siess et al. | Jun 2010 | B2 |
7758521 | Morris | Jul 2010 | B2 |
7766892 | Keren et al. | Aug 2010 | B2 |
7780628 | Keren et al. | Aug 2010 | B1 |
7785246 | Aboul-Hosn et al. | Aug 2010 | B2 |
7811279 | John | Oct 2010 | B2 |
7819833 | Ainsworth et al. | Oct 2010 | B2 |
7820205 | Takakusagi et al. | Oct 2010 | B2 |
7828710 | Shifflette | Nov 2010 | B2 |
7841976 | McBride et al. | Nov 2010 | B2 |
7878967 | Khanal | Feb 2011 | B1 |
7918828 | Lundgaard et al. | Apr 2011 | B2 |
7927068 | McBride et al. | Apr 2011 | B2 |
7935102 | Breznock et al. | May 2011 | B2 |
7942804 | Khaw | May 2011 | B2 |
7942844 | Moberg et al. | May 2011 | B2 |
7955365 | Doty | Jun 2011 | B2 |
7993259 | Kang et al. | Aug 2011 | B2 |
7998054 | Bolling | Aug 2011 | B2 |
7998190 | Gharib et al. | Aug 2011 | B2 |
8012079 | Delgado | Sep 2011 | B2 |
8025647 | Siess et al. | Sep 2011 | B2 |
8079948 | Shifflette | Dec 2011 | B2 |
8110267 | Houston et al. | Feb 2012 | B2 |
8114008 | Hidaka et al. | Feb 2012 | B2 |
8123669 | Siess et al. | Feb 2012 | B2 |
8177703 | Smith et al. | May 2012 | B2 |
8206350 | Mann et al. | Jun 2012 | B2 |
8209015 | Glenn | Jun 2012 | B2 |
8216122 | Kung | Jul 2012 | B2 |
8235943 | Breznock et al. | Aug 2012 | B2 |
8236040 | Mayberry et al. | Aug 2012 | B2 |
8236044 | Robaina | Aug 2012 | B2 |
8255050 | Mohl | Aug 2012 | B2 |
8257312 | Duffy | Sep 2012 | B2 |
8262619 | Chebator et al. | Sep 2012 | B2 |
8277470 | Demarais et al. | Oct 2012 | B2 |
8317715 | Belleville et al. | Nov 2012 | B2 |
8329913 | Murata et al. | Dec 2012 | B2 |
8333687 | Farnan et al. | Dec 2012 | B2 |
8348991 | Weber et al. | Jan 2013 | B2 |
8364278 | Pianca et al. | Jan 2013 | B2 |
8376707 | McBride et al. | Feb 2013 | B2 |
8382818 | Davis et al. | Feb 2013 | B2 |
8388565 | Shifflette | Mar 2013 | B2 |
8409128 | Ferrari | Apr 2013 | B2 |
8414645 | Dwork et al. | Apr 2013 | B2 |
8439859 | Pfeffer et al. | May 2013 | B2 |
8449443 | Rodefeld | May 2013 | B2 |
8485961 | Campbell et al. | Jul 2013 | B2 |
8489190 | Pfeffer et al. | Jul 2013 | B2 |
8535211 | Campbell et al. | Sep 2013 | B2 |
8540615 | Aboul-Hosn et al. | Sep 2013 | B2 |
8545379 | Marseille et al. | Oct 2013 | B2 |
8545380 | Farnan et al. | Oct 2013 | B2 |
8579858 | Reitan | Nov 2013 | B2 |
8585572 | Mehmanesh | Nov 2013 | B2 |
8591393 | Walters et al. | Nov 2013 | B2 |
8597170 | Walters et al. | Dec 2013 | B2 |
8617239 | Reitan | Dec 2013 | B2 |
8684904 | Campbell et al. | Apr 2014 | B2 |
8690749 | Nunez | Apr 2014 | B1 |
8721516 | Scheckel | May 2014 | B2 |
8721517 | Zeng et al. | May 2014 | B2 |
8727959 | Reitan et al. | May 2014 | B2 |
8734331 | Evans et al. | May 2014 | B2 |
8784441 | Rosenbluth et al. | Jul 2014 | B2 |
8790236 | LaRose et al. | Jul 2014 | B2 |
8795576 | Tao et al. | Aug 2014 | B2 |
8801590 | Mohl | Aug 2014 | B2 |
8814776 | Hastie et al. | Aug 2014 | B2 |
8814933 | Siess | Aug 2014 | B2 |
8849398 | Evans | Sep 2014 | B2 |
8944748 | Liebing | Feb 2015 | B2 |
8992406 | Corbett | Mar 2015 | B2 |
8998792 | Scheckel | Apr 2015 | B2 |
9028216 | Schumacher et al. | May 2015 | B2 |
9089634 | Schumacher et al. | Jul 2015 | B2 |
9089670 | Scheckel | Jul 2015 | B2 |
9162017 | Evans et al. | Oct 2015 | B2 |
9217442 | Wiessler et al. | Dec 2015 | B2 |
9308302 | Zeng | Apr 2016 | B2 |
9314558 | Er | Apr 2016 | B2 |
9327067 | Zeng et al. | May 2016 | B2 |
9328741 | Liebing | May 2016 | B2 |
9358330 | Schumacher | Jun 2016 | B2 |
20020107506 | McGuckin, Jr. et al. | Aug 2002 | A1 |
20030018380 | Craig et al. | Jan 2003 | A1 |
20030205233 | Aboul-Hosn et al. | Nov 2003 | A1 |
20030208097 | Aboul-Hosn et al. | Nov 2003 | A1 |
20030231959 | Snider | Dec 2003 | A1 |
20050049696 | Siess et al. | Mar 2005 | A1 |
20050085683 | Bolling et al. | Apr 2005 | A1 |
20050113631 | Bolling et al. | May 2005 | A1 |
20050137680 | Ortiz et al. | Jun 2005 | A1 |
20050165269 | Aboul-Hosn et al. | Jul 2005 | A9 |
20050250975 | Carrier et al. | Nov 2005 | A1 |
20060018943 | Bechert et al. | Jan 2006 | A1 |
20060058869 | Olson et al. | Mar 2006 | A1 |
20060063965 | Aboul-Hosn et al. | Mar 2006 | A1 |
20060089521 | Chang | Apr 2006 | A1 |
20060155158 | Aboul-Hosn | Jul 2006 | A1 |
20060264695 | Viole et al. | Nov 2006 | A1 |
20060270894 | Viole et al. | Nov 2006 | A1 |
20070100314 | Keren et al. | May 2007 | A1 |
20080004645 | To et al. | Jan 2008 | A1 |
20080103442 | Kesten et al. | May 2008 | A1 |
20080103516 | Wulfman et al. | May 2008 | A1 |
20080119943 | Armstrong et al. | May 2008 | A1 |
20080132748 | Shifflete | Jun 2008 | A1 |
20080167679 | Papp | Jul 2008 | A1 |
20080275290 | Viole et al. | Nov 2008 | A1 |
20090018567 | Escudero et al. | Jan 2009 | A1 |
20090024085 | To et al. | Jan 2009 | A1 |
20090099638 | Grewe | Apr 2009 | A1 |
20090112312 | LaRose et al. | Apr 2009 | A1 |
20090118567 | Siess | May 2009 | A1 |
20090182188 | Marseille et al. | Jul 2009 | A1 |
20090234378 | Escudero et al. | Sep 2009 | A1 |
20100030186 | Stivland | Feb 2010 | A1 |
20100041939 | Siess | Feb 2010 | A1 |
20100047099 | Miyazaki et al. | Feb 2010 | A1 |
20100127871 | Pontin | May 2010 | A1 |
20100210895 | Aboul-Hosn et al. | Aug 2010 | A1 |
20100268017 | Siess | Oct 2010 | A1 |
20100274330 | Burwell et al. | Oct 2010 | A1 |
20100286791 | Goldsmith | Nov 2010 | A1 |
20110071338 | McBride et al. | Mar 2011 | A1 |
20110076439 | Zeilon | Mar 2011 | A1 |
20110152906 | Escudero et al. | Jun 2011 | A1 |
20110152907 | Escudero et al. | Jun 2011 | A1 |
20110237863 | Ricci et al. | Sep 2011 | A1 |
20120004495 | Bolling | Jan 2012 | A1 |
20120029265 | LaRose et al. | Feb 2012 | A1 |
20120059213 | Spence | Mar 2012 | A1 |
20120083740 | Chebator | Apr 2012 | A1 |
20120142994 | Toellner | Jun 2012 | A1 |
20120172654 | Bates | Jul 2012 | A1 |
20120178986 | Campbell et al. | Jul 2012 | A1 |
20120184803 | Simon et al. | Jul 2012 | A1 |
20120224970 | Schumacher et al. | Sep 2012 | A1 |
20120226097 | Smith et al. | Sep 2012 | A1 |
20120234411 | Scheckel | Sep 2012 | A1 |
20120245404 | Smith et al. | Sep 2012 | A1 |
20120265002 | Roehn et al. | Oct 2012 | A1 |
20130041202 | Toellner | Feb 2013 | A1 |
20130053622 | Corbett | Feb 2013 | A1 |
20130053623 | Evans et al. | Feb 2013 | A1 |
20130066140 | McBride et al. | Mar 2013 | A1 |
20130085318 | Toellner | Apr 2013 | A1 |
20130096364 | Reichenbach et al. | Apr 2013 | A1 |
20130103063 | Escudero et al. | Apr 2013 | A1 |
20130106212 | Nakazumi et al. | May 2013 | A1 |
20130129503 | McBride et al. | May 2013 | A1 |
20130138205 | Kushwaha et al. | May 2013 | A1 |
20130204362 | Toellner et al. | Aug 2013 | A1 |
20130209292 | Baykut et al. | Aug 2013 | A1 |
20130237744 | Pfeffer et al. | Sep 2013 | A1 |
20130245360 | Schumacher | Sep 2013 | A1 |
20130303969 | Keenan et al. | Nov 2013 | A1 |
20130303970 | Keenan et al. | Nov 2013 | A1 |
20130331639 | Campbell et al. | Dec 2013 | A1 |
20130345492 | Pfeffer et al. | Dec 2013 | A1 |
20140005467 | Farnan et al. | Jan 2014 | A1 |
20140010686 | Tanner et al. | Jan 2014 | A1 |
20140012065 | Fitzgerald et al. | Jan 2014 | A1 |
20140039465 | Schulz et al. | Feb 2014 | A1 |
20140067057 | Callaway et al. | Mar 2014 | A1 |
20140088455 | Christensen et al. | Mar 2014 | A1 |
20140148638 | LaRose et al. | May 2014 | A1 |
20140163664 | Goldsmith | Jun 2014 | A1 |
20140255176 | Bredenbreuker et al. | Sep 2014 | A1 |
20140275725 | Schenck et al. | Sep 2014 | A1 |
20140275726 | Zeng et al. | Sep 2014 | A1 |
20140301822 | Scheckel | Oct 2014 | A1 |
20140303596 | Schumacher et al. | Oct 2014 | A1 |
20150025558 | Wulfman et al. | Jan 2015 | A1 |
20150031936 | LaRose et al. | Jan 2015 | A1 |
20150051435 | Siess et al. | Feb 2015 | A1 |
20150051436 | Spanier et al. | Feb 2015 | A1 |
20150080743 | Siess | Mar 2015 | A1 |
20150087890 | Spanier et al. | Mar 2015 | A1 |
20150141738 | Toellner et al. | May 2015 | A1 |
20150141739 | Hsu et al. | May 2015 | A1 |
20150151032 | Voskoboynikov | Jun 2015 | A1 |
20150209498 | Franono et al. | Jul 2015 | A1 |
20150250935 | Anderson et al. | Sep 2015 | A1 |
20150290372 | Muller et al. | Oct 2015 | A1 |
20150343179 | Schumacher et al. | Dec 2015 | A1 |
20160184500 | Zeng | Jun 2016 | A1 |
20160250399 | Tiller et al. | Sep 2016 | A1 |
20160250400 | Schumacher et al. | Sep 2016 | A1 |
20160256620 | Scheckel et al. | Sep 2016 | A1 |
Number | Date | Country |
---|---|---|
2701810 | Apr 2009 | CA |
0 533 432 | Sep 1992 | EP |
1 207 934 | May 2002 | EP |
1 393 762 | Mar 2004 | EP |
1 591 079 | Nov 2005 | EP |
2 263 732 | Dec 2010 | EP |
2 298 374 | Mar 2011 | EP |
2267800 | Apr 1974 | FR |
2 239 675 | Jul 1991 | GB |
S48-23295 | Mar 1973 | JP |
06-114101 | Apr 1994 | JP |
10-099447 | Apr 1998 | JP |
500877 | Sep 2002 | TW |
WO 8905164 | Jun 1989 | WO |
WO 9526695 | Oct 1995 | WO |
WO 9715228 | May 1997 | WO |
WO 9737697 | Oct 1997 | WO |
WO 0012148 | Mar 2000 | WO |
WO 0019097 | Apr 2000 | WO |
WO 0043062 | Jul 2000 | WO |
WO 0061207 | Oct 2000 | WO |
WO 0069489 | Nov 2000 | WO |
WO 0117581 | Mar 2001 | WO |
WO 0124867 | Apr 2001 | WO |
WO 02070039 | Sep 2002 | WO |
WO 03103745 | Dec 2003 | WO |
WO 2005089674 | Sep 2005 | WO |
WO 2005123158 | Dec 2005 | WO |
WO 2009073037 | Jun 2009 | WO |
WO 2009076460 | Jun 2009 | WO |
WO 2010127871 | Nov 2010 | WO |
WO 2010133567 | Nov 2010 | WO |
WO 2010149393 | Dec 2010 | WO |
WO 2011035926 | Mar 2011 | WO |
WO 2011035929 | Mar 2011 | WO |
WO 2011039091 | Apr 2011 | WO |
WO 2011076439 | Jun 2011 | WO |
WO 2011089022 | Jul 2011 | WO |
WO 2012007140 | Jan 2012 | WO |
WO 2012007141 | Jan 2012 | WO |
WO 2013160407 | Oct 2013 | WO |
WO 2014019274 | Feb 2014 | WO |
WO 2015063277 | May 2015 | WO |
Entry |
---|
Abiomed, “Impella 5.0 with the Impella Console, Circulatory Support System, Instructions for Use & Clinical Reference Manual,” Jun. 2010, in 122 pages. |
Abiomed—Recovering Hearts. Saving Lives., Impella 2.5 System, Instructions for Use, Jul. 2007, in 86 sheets. |
Aboul-Hosn et al., “The Hemopump: Clinical Results and Future Applications”, Assisted Circulation 4, 1995, in 14 pages. |
Barras et al., “Nitinol—Its Use in Vascular Surgery and Other Applications,” Eur. J. Vasc. Endovasc. Surg., 2000, pp. 564-569; vol. 19. |
Biscarini et al., “Enhanced Nitinol Properties for Biomedical Applications,” Recent Patents on Biomedical Engineering, 2008, pp. 180-196, vol. 1(3). |
Cardiovascular Diseases (CVDs) Fact Sheet No. 317; World Health Organization [Online], Sep. 2011. http://www.who.int/mediacentre/factsheets/fs317/en/index.html, accessed on Aug. 29, 2012. |
Compendium of Technical and Scientific Information for the HEMOPUMP Temporary Cardiac Assist System, Johnson & Johnson Interventional Systems, 1988, in 15 pages. |
Dekker et al., “Efficacy of a New lntraaortic Propeller Pump vs the Intraaortic Balloon Pump, An Animal Study”, Chest, Jun. 2003, vol. 123, No. 6, pp. 2089-2095. |
Duerig et al., “An Overview of Nitinol Medical Applications,” Materials Science Engineering, 1999, pp. 149-160; vol. A273. |
European Search Report received in European Patent Application No. 05799883.3, dated May 10, 2011, in 4 pages. |
Extended European Search Report received in European Patent Application No. 07753903.9, dated Oct. 8, 2012, in 7 pages. |
Extended European Search Report received in European Patent Application No. 13813687.4, dated Feb. 24, 2016, in 6 pages. |
Extended European Search Report received in European Patent Application No. 13813867.2, dated Feb. 26, 2016, in 6 pages. |
Extended European Search Report received in European Patent Application No. 14779928.2, dated Oct. 7, 2016, in 6 pages. |
Federal and Drug Administration 510(k) Summary for Predicate Device IMPELLA 2.5 (K112892), prepared Sep. 5, 2012. |
Grech, “Percutaneous Coronary Intervention. I: History and Development,” BMJ., May 17, 2003, pp. 1080-1082, vol. 326. |
Hsu et al., “Review of Recent Patents on Foldable Ventricular Assist Devices,” Recent Patents on Biomedical Engineering, 2012, pp. 208-222, vol. 5. |
Ide et al., “Evaluation of the Pulsatility of a New Pulsatile Left Ventricular Assist Device—the Integrated Cardioassist Catheter—in Dogs,” J. of Thorac and Cardiovasc Sur, Feb. 1994, pp. 569-0575, vol. 107(2). |
Ide et al., “Hemodynamic Evaluation of a New Left Ventricular Assist Device: An Integrated Cardioassist Catheter as a Pulsatile Left Ventricle-Femoral Artery Bypass,” Blackwell Scientific Publications, Inc., 1992, pp. 286-290, vol. 16(3). |
Impella CP®—Instructions for Use & Clinical Reference Manual (United States only), Abiomed, Inc., Jul. 2014, 148 pages, www.abiomed.com. |
Impella LD® with the Impella® Controller—Circulatory Support System—Instructions for Use & Clinical Reference Manual (United States only), Abiomed, Inc., Sep. 2010, 132 pages, www.abiomed.com. |
International Preliminary Examination Report received in International Patent Application No. PCT/US2003/04853, dated Jul. 26, 2004, in 5 pages. |
International Preliminary Examination Report received in International Patent Application No. PCT/US2003/04401, dated May 18, 2004, in 4 pages. |
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in International Patent Application No. PCT/US2005/033416, dated Mar. 20, 2007, in 7 pages. |
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in International Patent Application No. PCT/US2007/007313, dated Sep. 23, 2008, in 6 pages. |
International Preliminary Report on Patentability and Written Opinion received in International Patent Application No. PCT/US2014/020878, dated Sep. 15, 2015, in 8 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2005/033416, dated Dec. 11, 2006, in 8 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2007/007313, dated Mar. 4, 2008, in 6 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020382, dated Jul. 31, 2012, in 11 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020369, dated Jul. 30, 2012, in 10 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020553, dated Aug. 17, 2012, in 8 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020383, dated Aug. 17, 2012; in 9 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040798, dated Aug. 21, 2013, in 16 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040799, dated Aug. 21, 2013, in 19 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040809, dated Sep. 2, 2013, in 25 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048332, dated Oct. 16, 2013, in 17 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048343, dated Oct. 11, 2013, in 15 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2014/020878, dated May 7, 2014, in 13 pages. |
International Search Reort and Written Opinion received in International Patent Application No. PCT/US2015/026013, dated Jul. 8, 2015, in 12 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026014, dated Jul. 15, 2015, in 13 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026025, dated Jul. 20, 2015, in 12 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/025959, dated Aug. 28, 2015, in 16 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/025960, dated Sep. 3, 2015, in 15 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/045370, dated Nov. 18, 2015, in 12 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014371, dated May 2, 2016, in 18 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014379, dated Jul. 25, 2016, in 19 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014391, dated May 2, 2016, in 17 pages. |
International Search Report received in International Patent Application No. PCT/US2003/004401, dated Nov. 10, 2003, in 9 pages. |
International Search Report received in International Patent Application No. PCT/US2003/004853, dated Jul. 3, 2003, in 3 pages. |
International Search Report Written Opinion received in International Patent Application No. PCT/US2010/040847, dated Dec. 14, 2010, in 17 pages. |
JOMED Reitan Catheter Pump RCP, Percutaneous Circulatory Support, in 10 pages, believed to be published prior to Oct. 15, 2003. |
JOMED Reitan Catheter Pump RCP, Feb. 18, 2003, in 4 pages. |
Krishnamani et al., “Emerging Ventricular Assist Devices for Long-Term Cardiac Support,” National Review, Cardiology, Feb. 2010, pp. 71-76, vol. 7. |
Kunst et al., “Integrated unit for programmable control of the 21F Hemopump and registration of physiological signals,” Medical & Biological Engineering & Computing, Nov. 1994, pp. 694-696. |
Mihaylov et al., “Development of a New Introduction Technique for the Pulsatile Catheter Pump,” Artificial Organs, 1997, pp. 425-427; vol. 21(5). |
Mihaylov et al., “Evaluation of the Optimal Driving Mode During Left Ventricular Assist with Pulsatile Catheter Pump in Calves,” Artificial Organs, 1999, pp. 1117-1122; vol. 23(12). |
Minimally Invasive Cardiac Assist JOMED Catheter PumpTM, in 6 pages, believed to be published prior to Jun. 16, 1999. |
Morgan, “Medical Shape Memory Alloy Applications—The Market and its Products,” Materials Science and Engineering, 2004, pp. 16-23, vol. A 378. |
Morsink et al., “Numerical Modelling of Blood Flow Behaviour in the Valved Catheter of the PUCA-Pump, a LVAD,” The International Journal of Artificial Organs, 1997, pp. 277-284; vol. 20(5). |
Nishimura et al, “The Enabler Cannula Pump: A Novel Circulatory Support System,” The International Journal of Artificial Organs, 1999, pp. 317-323; vol. 22(5). |
Nullity Action against the owner of the German part DE 50 2007 005 015.6 of European patent EP 2 047 872 B1, dated Jul. 13, 2015, in 61 pages. |
Petrini et al., “Biomedical Applications of Shape Memory Alloys,” Journal of Metallurgy, 2011, pp. 1-15. |
Raess et al., “Impella 2.5,” J. Cardiovasc. Transl. Res., 2009, pp. 168-172, vol. 2(2). |
Rakhorst et al., “In Vitro Evaluation of the Influence of Pulsatile Intraventricular Pumping on Ventricular Pressure Patterns,” Artificial Organs, 1994, pp. 494-499, vol. 18(7). |
Reitan, Evaluation of a New Percutaneous Cardiac Assist Device, Department of Cardiology, Faculty of Medicine, Lund University, Sweden, 2002, in 172 pages. |
Reitan et al., “Hemodynamic Effects of a New Percutaneous Circulatory Support Device in a Left Ventricular Failure Model,” ASAIO Journal, 2003, pp. 731-736, vol. 49. |
Reitan et al., “Hydrodynamic Properties of a New Percutaneous Intra-Aortic Axial Flow Pump,” ASAIO Journal 2000, pp. 323-328. |
Rothman, “The Reitan Catheter Pump: A New Versatile Approach for Hemodynamic Support”, London Chest Hospital Barts & The London NHS Trust, Oct. 22-27, 2006 (TCT 2006: Transcatheter Cardiovascular Therapeutics 18th Annual Scientific Symposium, Final Program), in 48 pages. |
Schmitz-Rode et al., “An Expandable Percutaneous Catheter Pump for Left Ventricular Support,” Journal of the American College of Cardiology, 2005, pp. 1856-1861, vol. 45(11). |
Shabari et al., “Improved Hemodynamics with a Novel Miniaturized Intra-Aortic Axial Flow Pump in a Porcine Model of Acute Left Ventricular Dysfunction,” ASAIO Journal, 2013, pp. 240-245; vol. 59. |
Sharony et al, “Cardiopulmonary Support and Physiology—The Intra-Aortic Cannula Pump: A Novel Assist Device for the Acutely Failing Heart,” The Journal of Thoracic and Cardiovascular Surgery, Nov. 1992, pp. 924-929, vol. 118(5). |
Sharony et al., “Right Heart Support During Off-Pump Coronary Artery Surgery—A Multi-Center Study,” The Heart Surgery Forum, 2002, pp. 13-16, vol. 5(1). |
Sieß et al., “Hydraulic refinement of an intraarterial microaxial blood pump”, The International Journal of Artificial Organs, 1995, vol. 18, No. 5, pp. 273-285. |
Sieß, “Systemanalyse und Entwicklung intravasaler Rotationspumpen zur Herzunterstützung”, Helmholtz-Institut fur Blomedixinische Technik an der RWTH Aachen, Jun. 24, 1998, in 105 pages. |
Siess et al., “Basic design criteria for rotary blood pumps,” H. Masuda, Rotary Blood Pumps, Springer, Japan, 2000, pp. 69-83. |
Siess et al., “Concept, realization, and first in vitro testing of an intraarterial microaxial blood pump,” Artificial Organs, 1995, pp. 644-652, vol. 19, No. 7, Blackwell Science, Inc., Boston, International Society for Artificial Organs. |
Siess et al., “From a lab type to a product: A retrospective view on Impella's assist technology,” Artificial Organs, 2001, pp. 414-421, vol. 25, No. 5, Blackwell Science, Inc., International Society for Artificial Organs. |
Siess et al., “System analysis and development of intravascular rotation pumps for cardiac assist,” Dissertation, Shaker Verlag, Aachen, 1999, 39 pages. |
Smith et al., “First-In-Man Study of the Reitan Catheter Pump for Circulatory Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention,” Catheterization and Cardiovascular Interventions, 2009, pp. 859-865, vol. 73(7). |
Sokolowski et al., “Medical Applications of Shape Memory Polymers,” Biomed. Mater. 2007, pp. S23-S27, vol. 2. |
“Statistical Analysis and Clinical Experience with the Recover® Pump Systems”, Impella CardioSystems GmbH, Sep. 2005, 2 sheets. |
Stoeckel et al., “Self-Expanding Nitinol Stents—Material and Design Considerations,” European Radiology, 2003, in 13 sheets. |
Stolinski et al., “The heart-pump interaction: effects of a microaxial blood pump,” International Journal of Artificial Organs, 2002, pp. 1082-1088, vol. 25, Issue 11. |
Supplemental European Search Report received from the European Patent Office in EP Application No. EP 05799883 dated Mar. 19, 2010, 3 pages. |
Takagaki et al., “A Novel Miniature Ventricular Assist Device for Hemodynamic Support,” ASAIO Journal, 2001, pp. 412-416; vol. 47. |
Throckmorton et al., “Flexible Impeller Blades in an Axial Flow Pump for Intravascular Cavopulmonary Assistance of the Fontan Physiology,” Cardiovascular Engineering and Technology, Dec. 2010, pp. 244-255, vol. 1(4). |
Throckmorton et al., “Uniquely shaped cardiovascular stents enhance the pressure generation of intravascular blood pumps,” The Journal of Thoracic and Cardiovascular Surgery, Sep. 2012, pp. 704-709, vol. 133, No. 3. |
Verkerke et al., “Numerical Simulation of the PUCA Pump, A Left Ventricular Assist Device,” Abstracts of the XIXth ESAO Congress, The International Journal of Artificial Organs, 1992, p. 543, vol. 15(9). |
Verkerke et al., “Numerical Simulation of the Pulsating Catheter Pump: A Left Ventricular Assist Device,” Artificial Organs, 1999, pp. 924-931, vol. 23(10). |
Verkerke et al., “The PUCA Pump: A Left Ventricular Assist Device,” Artificial Organs, 1993, pp. 365-368, vol. 17(5). |
Wampler et al., “The Sternotomy Hemopump, A Second Generation Intraarterial Ventricular Assist Device,” ASAIO Journal, 1993, pp. M218-M223, vol. 39. |
Weber et al., “Principles of Impella Cardiac Support,” Supplemental to Cardiac Interventions Today, Aug./Sep. 2009. |
Written Opinion received in International Patent Application No. PCT/US2003/04853, dated Feb. 25, 2004, 5 pages. |
Number | Date | Country | |
---|---|---|---|
20170035952 A1 | Feb 2017 | US |
Number | Date | Country | |
---|---|---|---|
61979937 | Apr 2014 | US |